In addition, HTB182 and CRL5928 were relatively resistant compared to other lung cancer cells as more than 60% of the cells were still alive at high dose VSV (MOI5) even without exogenous IFNα pretreatment (Figure 1A). This evidence concerns the gene IFNA1 and lung cancer.